Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome (vol 25, pg 752, 2024)

被引：0
|
作者：
Battaglia, Muriel R. [1 ]
Cannova, Joseph [2 ]
Madero-Marroquin, Rafael [2 ]
Patel, Anand A. [2 ]
机构：
[1] Univ Chicago, Dept Med, Chicago, IL USA
[2] Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave MC 2115, Chicago, IL 60637 USA
来源：
CURRENT TREATMENT OPTIONS IN ONCOLOGY | 2024年
关键词：
D O I：
10.1007/s11864-024-01263-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1335 / 1335
页数：1
相关论文
共 50 条
  • [1] Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome
    Battaglia, Muriel R.
    Cannova, Joseph
    Madero-Marroquin, Rafael
    Patel, Anand A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (06) : 752 - 768
  • [2] Lower-risk myelodysplastic syndromes: Current treatment options for anemia
    Meunier, Mathieu
    Park, Sophie
    EJHAEM, 2022, 3 (04): : 1091 - 1099
  • [3] Focus on Anemia in Managing Lower-Risk Myelodysplastic Syndromes
    Chung, Clement
    US PHARMACIST, 2021, 46 (09) : 39 - 44
  • [4] Activity of Luspatercept and ESAs Combination for Treatment of Anemia in Lower-Risk Myelodysplastic Syndromes
    Al Ali, Najla
    Luis, Aguirre
    Onyee, Chan
    Kuykendall, Andrew
    Lancet, Jeffrey
    Padron, Eric
    Sallman, David
    Komrokji, Rami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S363 - S364
  • [5] Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes
    Komrokji, Rami S.
    Aguirre, Luis E.
    Al Ali, Najla H.
    Chan, Onyee
    Xie, Zhuoer
    Kuykendall, Andrew
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    BLOOD ADVANCES, 2023, 7 (14) : 3677 - 3679
  • [6] Androgen Therapy for Lower-Risk Myelodysplastic Syndrome
    Choi, Eun-Ji
    Lee, Je-Hwan
    Park, Han-Seung
    Lee, Jung-Hee
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Woo, Ji Min
    Lee, Kyoo Hyung
    BLOOD, 2018, 132
  • [7] Luspatercept in the treatment of lower-risk myelodysplastic syndromes
    Chan, Onyee
    Komrokji, Rami S.
    FUTURE ONCOLOGY, 2021, 17 (12) : 1473 - 1481
  • [8] Cause of Death in Patients With Lower-Risk Myelodysplastic Syndrome
    Dayyani, Farshid
    Conley, Anthony P.
    Strom, Sara S.
    Stevenson, William
    Cortes, Jorge E.
    Borthakur, Gautam
    Fader, Stefan
    O'Brien, Susan
    Pierce, Sherry
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    CANCER, 2010, 116 (09) : 2174 - 2179
  • [9] Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndrome
    Komrokji, Rami S.
    Lancet, Jeffrey E.
    Swern, Arlene S.
    Chen, Nianhang
    Paleveda, Jennifer
    Lush, Richard
    Saba, Hussain I.
    List, Alan F.
    BLOOD, 2012, 120 (17) : 3419 - 3424
  • [10] Extended Abstract: Treatment of Lower-Risk Myelodysplastic Syndromes
    Steensma, David P.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S17 - S18
12345